2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

• Published in: Journal of the American College of Cardiology 2009-12, Vol.54 (23), p.2205-2241
• Main Authors: Kushner, Frederick G, Hand, Mary, Smith, Jr, Sidney C, King, 3rd, Spencer B, Anderson, Jeffrey L, Antman, Elliott M, Bailey, Steven R, Bates, Eric R, Blankenship, James C, Casey, Jr, Donald E, Green, Lee A, Hochman, Judith S, Jacobs, Alice K, Krumholz, Harlan M, Morrison, Douglass A, Ornato, Joseph P, Pearle, David L, Peterson, Eric D, Sloan, Michael A, Whitlow, Patrick L, Williams, David O
• Format: Article
• Language: English
• Subjects: Angioplasty, Balloon, Coronary - standards; Anticoagulants; Cardiology; Coronary vessels; Electrocardiography; Heart attacks; Humans; Myocardial Infarction - physiopathology; Myocardial Infarction - therapy; Practice Guidelines as Topic - standards; Societies, Medical; United States
• ISSN: 0735-1097; 1558-3597
• DOI: 10.1016/j.jacc.2009.10.015

In an effort to respond promptly to new evidence, the American College of Cardiology Foundation/American Heart Association (ACCF/AHA) Task Force on Practice Guidelines has created a "focused update" process to revise the existing guideline recommendations that are affected by evolving data or opinion. Specific criteria/considerations for inclusion of new data include the following: publication in a peer-reviewed journal; large randomized, placebo-controlled trial(s); nonrandomized data deemed important on the basis of results that affect current safety and efficacy assumptions; strength/weakness of research methodology and findings; likelihood of additional studies influencing current findings; impact on current performance measure(s) and/or likelihood of need to develop new performance measure(s); requests and requirements for review and update from the practice community, key stakeholders, and other sources free of relationships with industry or other potential bias; number of previous trials showing consistent results; and need for consistency with a new guideline or guideline revision. Death/MI/CVA/revascularization: 15.8 versus 13.7; P=0.44 Appendix 6 Outcomes of PCI Versus CABG for Unprotected Left Main Coronary Artery Disease CABG indicates coronary artery bypass graft surgery; CI, confidence interval; CVA, cerebrovascular accident; HR, hazard ratio; MACE, major adverse cardiac events; MI, myocardial infarction; NS, not significant; OR, odds ratio; RR, relative risk; and PCI, percutaneous coronary intervention.When possible, 95% CIs reported were provided for RR, OR, or HR calculations along with probability values.